Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Low-density lipoprotein heterogeneity

B A Griffin1

  • 1School of Biological Sciences, University of Surrey, Guildford, UK.

Bailliere'S Clinical Endocrinology and Metabolism
|October 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elevated high density lipoprotein cholesterol and low grade systemic inflammation is associated with increased gut permeability in normoglycemic men.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2018
Same author

Chasing balance and other recommendations for improving nonparametric propensity score models.

Journal of causal inference·2018
Same author

Relevance of liver fat to the impact of dietary extrinsic sugars on lipid metabolism.

The Proceedings of the Nutrition Society·2015
Same author

Plasma free fatty acids do not provide the link between obesity and insulin resistance or β-cell dysfunction: results of the Reading, Imperial, Surrey, Cambridge, Kings (RISCK) study.

Diabetic medicine : a journal of the British Diabetic Association·2014
Same author

Dietary patterns and cardiovascular disease.

The Proceedings of the Nutrition Society·2013
Same author

Neighborhood socioeconomic status and coronary heart disease risk prediction in a nationally representative sample.

Public health·2012
Same journal

Phytoestrogen content in foods.

Bailliere's clinical endocrinology and metabolism·1999
Same journal

Soyfoods, isoflavones and risk of colonic cancer: a review of the in vitro and in vivo data.

Bailliere's clinical endocrinology and metabolism·1999
Same journal

Experimental studies on lignans and cancer.

Bailliere's clinical endocrinology and metabolism·1999
Same journal

Reproductive actions of phytoestrogens.

Bailliere's clinical endocrinology and metabolism·1999
Same journal

Phytoestrogens and inhibition of angiogenesis.

Bailliere's clinical endocrinology and metabolism·1999
Same journal

Phytoestrogens and diseases of the prostate gland.

Bailliere's clinical endocrinology and metabolism·1999
See all related articles

Raised small, dense low-density lipoprotein (LDL) is linked to coronary heart disease (CHD) risk. Further research into LDL heterogeneity

Area of Science:

  • Cardiovascular Science
  • Lipid Metabolism
  • Genetics

Background:

  • Atherogenic Lipoprotein Phenotype (ALP) characterized by elevated small, dense LDL is common.
  • Small, dense LDL is associated with increased coronary heart disease (CHD) risk.
  • Current screening methods for LDL subclasses have practical limitations.

Purpose of the Study:

  • To explore the metabolic and genetic determinants of LDL heterogeneity.
  • To investigate alternative analytical methods for LDL subclasses and genotypes.
  • To understand how diet and drugs influence LDL heterogeneity via post-prandial responses.

Main Methods:

  • Analysis of LDL subclasses and their structural/functional properties.
  • Investigation of post-prandial lipemia and VLDL levels.

Related Experiment Videos

  • Twin studies to assess genetic and environmental influences on LDL heterogeneity.

    • Main Results:

    • Small, dense LDL is a significant risk factor for CHD.
    • Genetic factors play a role in LDL subclass variation, but environmental factors are key modulators.
    • Interactions between diet and genes influencing LDL heterogeneity are complex and understudied.

    Conclusions:

    • Elucidating the molecular basis of small, dense LDL's role in atherogenesis is crucial.
    • Identifying genetically susceptible individuals is key for targeted interventions.
    • Developing appropriate diets and treatments to mitigate CHD risk mediated by LDL is essential.